Ozempic's Semaglutide Shows Promise in Reducing Kidney Disease Risk for Type 2 Diabetes Patients Medicine & Technology May 25, 2024 Discover how Ozempic's semaglutide shows promise in reducing kidney disease risk for Type 2 diabetes patients. Learn more about this groundbreaking development. Read now!
Ozempic Reduces Alcohol and Nicotine Cravings, Novo Nordisk to Investigate Further May 20, 2024 Learn how Ozempic reduces alcohol and nicotine cravings. Novo Nordisk to investigate further. Stay informed on this promising development. Read more!
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts